The European Medicines Agency (EMA) supported this Thursday the authorization in European Union use of vaccines adapted to new variants of SARS-CoV-2 developed by pharmaceutical companies Pfizer and Moderna as an enhancer for broader protection against COVID-19 in people over 12 years of age.
After an extraordinary meeting at its headquarters in Amsterdam EMA He explained that adapted vaccines “may enhance protection against different variants and therefore are expected to help maintain optimal protection” against the virus. COVID-19 as the virus develops.
New injections can be given no earlier than 3 months after the last dose received from vaccine against him COVID-19.
The US also gives permission
U.S. health authorities on Wednesday approved a new version of Pfizer’s and Moderna’s COVID-19 vaccines for the omicron variant to quickly launch a new immunization campaign.
Two updated vaccines have been approved for booster doses starting at 12 years of age. pfizer and from 18 years old modernThis is stated in a statement by the US Food and Drug Administration (FDA).
(According to AFP and EFE)
Source: RPP
I’m Liza Grey, an experienced news writer and author at the Buna Times. I specialize in writing about economic issues, with a focus on uncovering stories that have a positive impact on society. With over seven years of experience in the news industry, I am highly knowledgeable about current events and the ways in which they affect our daily lives.